Kline Kyle, Senior Vice President and CFO of Globus Medical Inc. ($GMED), sold about $2 million worth of company shares on the open market in two transactions over the last year. His most recent sale occurred on January 8, 2026. These sales rank him 3,470th out of nearly 12,000 insiders by total value sold, below the average of $8.6 million across about six transactions per insider. Kyle made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 21, 2026 | GLOBUS MEDICAL INC | $GMED | Kline Kyle | Senior Vice President, CFO | A | Stock Option (Right to Buy Class A Common Stock) | 30000 | $0.00 | 30,000.0000 | 137,219,000 | 9999.99% | 0.02% |
| Dec. 1, 2025 | GLOBUS MEDICAL INC | $GMED | Kline Kyle | Senior Vice President, CFO | M | Stock Option (Right to Buy Class A Common Stock) | 4896 | $0.00 | 104.0000 | 137,219,000 | 97.92% | 0.00% |
| Jan. 8, 2026 | GLOBUS MEDICAL INC | $GMED | Kline Kyle | Senior Vice President, CFO | M | Class A Common Stock | 3594 | $51.87 | 3,594.0000 | 137,219,000 | 9999.99% | 0.00% |
| Jan. 8, 2026 | GLOBUS MEDICAL INC | $GMED | Kline Kyle | Senior Vice President, CFO | S | Class A Common Stock | 3594 | $101.10 | 0.0000 | 137,219,000 | 100.00% | 0.00% |
| Jan. 8, 2026 | GLOBUS MEDICAL INC | $GMED | Kline Kyle | Senior Vice President, CFO | M | Stock Option (Right to Buy Class A Common Stock) | 3594 | $0.00 | 3,906.0000 | 137,219,000 | 47.92% | 0.00% |
| Dec. 1, 2025 | GLOBUS MEDICAL INC | $GMED | Kline Kyle | Senior Vice President, CFO | S | Class A Common Stock | 18542 | $90.00 | 0.0000 | 137,219,000 | 100.00% | 0.01% |
| Dec. 1, 2025 | GLOBUS MEDICAL INC | $GMED | Kline Kyle | Senior Vice President, CFO | M | Stock Option (Right to Buy Class A Common Stock) | 3646 | $0.00 | 1,354.0000 | 137,219,000 | 72.92% | 0.00% |
| Dec. 1, 2025 | GLOBUS MEDICAL INC | $GMED | Kline Kyle | Senior Vice President, CFO | M | Stock Option (Right to Buy Class A Common Stock) | 5000 | $0.00 | 10,000.0000 | 137,219,000 | 33.33% | 0.00% |
| Dec. 1, 2025 | GLOBUS MEDICAL INC | $GMED | Kline Kyle | Senior Vice President, CFO | M | Stock Option (Right to Buy Class A Common Stock) | 5000 | $0.00 | 0.0000 | 137,219,000 | 100.00% | 0.00% |
| Dec. 1, 2025 | GLOBUS MEDICAL INC | $GMED | Kline Kyle | Senior Vice President, CFO | M | Stock Option (Right to Buy Class A Common Stock) | 5000 | $0.00 | 0.0000 | 137,219,000 | 100.00% | 0.00% |
| Dec. 1, 2025 | GLOBUS MEDICAL INC | $GMED | Kline Kyle | Senior Vice President, CFO | M | Class A Common Stock | 3646 | $53.14 | 3,646.0000 | 137,219,000 | 9999.99% | 0.00% |
| Dec. 1, 2025 | GLOBUS MEDICAL INC | $GMED | Kline Kyle | Senior Vice President, CFO | M | Class A Common Stock | 5000 | $56.43 | 8,646.0000 | 137,219,000 | 137.14% | 0.00% |
| Dec. 1, 2025 | GLOBUS MEDICAL INC | $GMED | Kline Kyle | Senior Vice President, CFO | M | Class A Common Stock | 5000 | $64.44 | 13,646.0000 | 137,219,000 | 57.83% | 0.00% |
| Dec. 1, 2025 | GLOBUS MEDICAL INC | $GMED | Kline Kyle | Senior Vice President, CFO | M | Class A Common Stock | 4896 | $63.68 | 18,542.0000 | 137,219,000 | 35.88% | 0.00% |
| July 18, 2025 | GLOBUS MEDICAL INC | $GMED | Kline Kyle | Senior Vice President, CFO | A | Stock Option (Right to Buy Class A Common Stock) | 20909 | $0.00 | 20,909.0000 | 137,863,000 | 9999.99% | 0.02% |